These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17637938)

  • 1. Spotlight on autoimmune lymphoproliferative syndrome.
    Ferrer E; Moral MA; Bozzo J
    Drug News Perspect; 2007 May; 20(4):260-2. PubMed ID: 17637938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Autoimmune lymphoproliferative syndrome: an inherited or a somatic defect of apoptosis].
    Rieux-Laucat F
    Med Sci (Paris); 2006; 22(6-7):645-50. PubMed ID: 16828042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype.
    Worth A; Thrasher AJ; Gaspar HB
    Br J Haematol; 2006 Apr; 133(2):124-40. PubMed ID: 16611303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome.
    Straus SE; Sneller M; Lenardo MJ; Puck JM; Strober W
    Ann Intern Med; 1999 Apr; 130(7):591-601. PubMed ID: 10189330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The autoimmune lymphoproliferative syndrome: a disorder of programmed cell death].
    Seegers D; Peña AS; Bouma G
    Ned Tijdschr Geneeskd; 2004 Feb; 148(8):371-6. PubMed ID: 15032090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid regression of lymphadenopathy upon rapamycin treatment in a child with autoimmune lymphoproliferative syndrome.
    Janić MD; Brasanac CD; Janković JS; Dokmanović BL; Krstovski RN; Kraguljac Kurtović JN
    Pediatr Blood Cancer; 2009 Dec; 53(6):1117-9. PubMed ID: 19588524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune lymphoproliferative syndrome, a disorder of apoptosis.
    Jackson CE; Puck JM
    Curr Opin Pediatr; 1999 Dec; 11(6):521-7. PubMed ID: 10590910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune lymphoproliferative syndrome (ALPS) caused by Fas (CD95) mutation mimicking sarcoidosis.
    Müllauer L; Emhofer J; Wohlfart S; Pichlhöfer B; Stary S; Ebetsberger G; Mannhalter C; Chott A
    Am J Surg Pathol; 2008 Feb; 32(2):329-34. PubMed ID: 18223337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune lymphoproliferative syndrome (ALPS): a case with congenital onset.
    Kahwash SB; Fung B; Savelli S; Bleesing JJ; Qualman SJ
    Pediatr Dev Pathol; 2007; 10(4):315-9. PubMed ID: 17638424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune lymphoproliferative syndrome: report of two cases and review of the literature.
    Oren H; Ozkal S; Gülen H; Duman M; Uçar C; Atabay B; Yilmaz S; Kargi A; Irken G
    Ann Hematol; 2002 Nov; 81(11):651-3. PubMed ID: 12454704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle regulation by FasL and Apo2L/TRAIL in human T-cell blasts. Implications for autoimmune lymphoproliferative syndromes.
    Bosque A; Aguiló JI; del Rey M; Paz-Artal E; Allende LM; Naval J; Anel A
    J Leukoc Biol; 2008 Aug; 84(2):488-98. PubMed ID: 18483205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The autoimmune lymphoproliferative syndrome (Canale-Smith) in adulthood.
    Deutsch M; Tsopanou E; Dourakis SP
    Clin Rheumatol; 2004 Feb; 23(1):43-4. PubMed ID: 14749982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous manifestations as presenting sign of autoimmune lymphoproliferative syndrome in childhood.
    Auricchio L; Vitiello L; Adriani M; Ferri P; Chiocchetti A; Pettinato G; Racioppi L; Maiuri L; Dianzani U; Pignata C
    Dermatology; 2005; 210(4):336-40. PubMed ID: 15942224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-death signaling and human disease.
    Rieux-Laucat F; Fischer A; Deist FL
    Curr Opin Immunol; 2003 Jun; 15(3):325-31. PubMed ID: 12787759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune lymphoproliferative syndrome.
    Sneller MC; Dale JK; Straus SE
    Curr Opin Rheumatol; 2003 Jul; 15(4):417-21. PubMed ID: 12819469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune lymphoproliferative syndrome: a cause of chronic splenomegaly, lymphadenopathy, and cytopenias in children-report on diagnosis and management of five patients.
    Alvarado CS; Straus SE; Li S; Dale JK; Mann K; Le A; Lauer SJ
    Pediatr Blood Cancer; 2004 Aug; 43(2):164-9. PubMed ID: 15236285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geoepidemiology and autoimmune manifestations of lymphoproliferative disorders.
    Sands J; Tuscano JM
    Autoimmun Rev; 2010 Mar; 9(5):A335-41. PubMed ID: 19914405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS).
    Teachey DT; Obzut DA; Axsom K; Choi JK; Goldsmith KC; Hall J; Hulitt J; Manno CS; Maris JM; Rhodin N; Sullivan KE; Brown VI; Grupp SA
    Blood; 2006 Sep; 108(6):1965-71. PubMed ID: 16757690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune lymphoproliferative syndrome type III: an indefinite disorder.
    Van Der Werff Ten Bosch J; Otten J; Thielemans K
    Leuk Lymphoma; 2001 Mar; 41(1-2):55-65. PubMed ID: 11342357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune lymphoproliferative syndrome (ALPS). Case report and family history.
    Ries F; Ferster A; Rieux-Laucat F; Biwer A; Dicato M
    Bull Soc Sci Med Grand Duche Luxemb; 2010; (2):271-8. PubMed ID: 20882745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.